Clinical trials
Completed Infertility trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,018 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 6 |
| 2001 | 9 |
| 2002 | 10 |
| 2003 | 18 |
| 2004 | 18 |
| 2005 | 23 |
| 2006 | 28 |
| 2007 | 26 |
| 2008 | 44 |
| 2009 | 54 |
| 2010 | 48 |
| 2011 | 48 |
| 2012 | 59 |
| 2013 | 62 |
| 2014 | 80 |
| 2015 | 56 |
| 2016 | 51 |
| 2017 | 45 |
| 2018 | 71 |
| 2019 | 45 |
| 2020 | 48 |
| 2021 | 34 |
| 2022 | 43 |
| 2023 | 28 |
| 2024 | 28 |
| 2025 | 15 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,018 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ferring Pharmaceuticals | 33 |
| Cairo University | 29 |
| Merck KGaA, Darmstadt, Germany | 25 |
| Universitair Ziekenhuis Brussel | 22 |
| Ibn Sina Hospital | 17 |
| Reproductive Medicine Associates of New Jersey | 17 |
| Royan Institute | 17 |
| Clinique Ovo | 13 |
| Instituto Valenciano de Infertilidad, IVI VALENCIA | 13 |
| Fundacion Dexeus | 12 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Infertility | 1,018 |
| Infertility, Female | 54 |
| Polycystic Ovary Syndrome | 51 |
| Endometriosis | 24 |
| Infertility, Male | 20 |
| Anovulation | 19 |
| Abortion, Spontaneous | 16 |
| Obesity | 14 |
| Pain | 14 |
| Anxiety Disorders | 11 |
Trials
Showing 1 to 25 of 1,018. Each trial links to its page on Pharma Observatory.
918 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.